Position in GRFS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$96,464
-$45,032 QoQ
Shares Held
13,625
-22.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#97
of 164 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $78,181,149 across 13 Drug Manufacturers - General names. GRFS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,846 | $22,604,455 | |
| 2 | JNJ |
Johnson & Johnson
|
70,352 | $17,867,294 | |
| 3 | ABBV |
AbbVie Inc.
|
35,888 | $9,030,853 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
63,356 | $8,004,392 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,325 | $5,310,262 | |
| 6 | PFE |
Pfizer Inc
|
157,175 | $3,784,771 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
55,716 | $3,210,352 | |
| 8 | AMGN |
Amgen Inc
|
7,847 | $2,841,552 |
All Filings in GRFS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,464 | 13,625 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $141,496 | 17,643 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $152,600 | 16,321 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $175,265 | 17,597 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $141,439 | 15,646 | Shares | Other | 2025-07-21 | |
| No filing history on record for this holder in this stock. | ||||||